Publications by authors named "Arshad Ali Shaikh"

Specialized metabolites produced by microorganisms found in ocean sediments display a wide range of clinically relevant bioactivities, including antimicrobial, anticancer, antiviral, and anti-inflammatory. Due to limitations in our ability to culture many benthic microorganisms under laboratory conditions, their potential to produce bioactive compounds remains underexplored. However, the advent of modern mass spectrometry technologies and data analysis methods for chemical structure prediction has aided in the discovery of such metabolites from complex mixtures.

View Article and Find Full Text PDF

While persistent efforts are being made to develop a novel arsenal against bacterial pathogens, the development of such materials remains a formidable challenge. One such strategy is to develop a multimodel antibacterial agent which will synergistically combat bacterial pathogens, including multidrug-resistant bacteria. Herein, we used pediocin, a class IIa bacteriocin, to decorate Ag° and developed a double-edged nanoplatform (Pd-SNPs) that inherits intrinsic properties of both antibacterial moieties, which engenders strikingly high antibacterial potency against a broad spectrum of bacterial pathogens including the ESKAPE category without displaying adverse cytotoxicity.

View Article and Find Full Text PDF
Article Synopsis
  • Bacterial specialized metabolites have significant applications in medicine, industry, and agriculture, but many potential compounds remain underexplored due to low expression of related biosynthetic gene clusters.
  • The study applied overexpression techniques and advanced metabolomics to identify and annotate 28 previously unreported metabolites, with many resembling those found in plants, suggesting that the bacteria can produce these compounds under certain conditions.
  • The research highlights the benefits of combining traditional strain engineering with modern metabolomics to enhance the discovery of novel natural products quickly and cost-effectively.
View Article and Find Full Text PDF

Clavulanic acid is a bacterial specialized metabolite, which inhibits certain serine β-lactamases, enzymes that inactivate β-lactam antibiotics to confer resistance. Due to this activity, clavulanic acid is widely used in combination with penicillin and cephalosporin (β-lactam) antibiotics to treat infections caused by β-lactamase-producing bacteria. Clavulanic acid is industrially produced by fermenting , as large-scale chemical synthesis is not commercially feasible.

View Article and Find Full Text PDF